-
Medication therapy strategies for the coronavirus disease 2019 (COVID-19): re...
The coronavirus disease 2019 (COVID-19) pandemic has spread globally since it outbroke in December 2019. The urgent pandemic presents an unprecedented challenge to develop and... -
Community-level environmental characteristics predictive of childhood stuntin...
Coastal morphology makes Bangladesh vulnerable to environmental hazards and climate change. Therefore, environmental characteristics may shape population health, including child... -
Systematic literature review of the epidemiology and clinical burden of chron...
We conducted a systematic literature review (SLR) to determine the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyps (CRSwNP) and to describe how the... -
Respiratory depression following medications for opioid use disorder (MOUD)-a...
Medications for opioid use disorder (MOUD) including buprenorphine is recommended for patients with opioid use disorders. We sought to evaluate the frequencies of respiratory... -
Treatment patterns and direct medical costs among patients with advanced hepa...
This study assessed the real-world United States (US) treatment patterns and the associated economic burden in patients diagnosed with advanced hepatocellular carcinoma (HCC).... -
Methylation Status of VDR Gene and its Association with Vitamin D Status and ...
Deficiency in circulatory vitamin D level and vitamin D receptor DNA methylation could be associated with weakened innate immune response and increased susceptibility to... -
From pigments to coloured napkins: comparative analyses of primary aromatic a...
A collaborative study was conducted to understand the correlation between pigments purity profile (primary aromatic amine content of the pigments) and the behaviour of these... -
dedup_wf_001--16ef9aab2b3d27815057c8b58c0c3edb
Rivaroxaban is a highly selective factor Xa inhibitor approved for use in Europe for multiple indications. The European rivaroxaban epidemiological post-authorization safety... -
Anti-HCV prevalence and risk factor-based screening for hepatitis C in pregna...
The hepatitis C virus (HCV) prevalence in Sweden is estimated to be <0.5%, but unclear in pregnant women. The dominating route of transmission is drug use (DU), blood...
